4-Bromo-4’-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells: in silico-guided analysis, synthesis, and in vitro cytotoxicity

References

• Abd El-Karim, S. S., Syam, Y. M., El Kerdawy, A. M., & Abdelghany, T. M. (2019). New thiazol-hydrazono-coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies. Bioorganic Chemistry, 86, 80–96. doi: 10.1016/j.bioorg.2019.01.026
   PubMed Web of Science ®Google Scholar
• Ackova, D. G., Smilkov, K., & Bosnakovski, D. (2019). Contemporary formulations for drug delivery of anticancer bioactive compounds. Recent Patents on Anti-Cancer Drug Discovery, 14(1), 19–31. 666190111104834. [Epub ahead of print] doi: 10.2174/1574892814
   PubMed Web of Science ®Google Scholar
• Ali, I., Haque, A., Saleem, K., & Hsieh, M. F. (2013a). Curcumin-I Knoevenagel’s condensates and their Schiff’s bases as anticancer agents: Synthesis, pharmacological and simulation studies. Bioorganic and Medicinal Chemistry, 21(13), 3808–3820. doi: 10.1016/j.bmc.2013.04.018
   PubMed Web of Science ®Google Scholar
• Ali, I., Saleem, K., Wesselinova, D., & Haque, A. (2013). Synthesis, DNA binding, hemolytic, and anti-cancer assays of curcumin I-based ligands and their ruthenium (III) complexes. Medicinal Chemistry Research, 22(3), 1386–1398. doi: 10.1007/s00044-012-0133-8
   Web of Science ®Google Scholar
• Athar, M., Lone, M. Y., Khedkar, V. M., & Jha, P. C. (2016). Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design. Journal of Biomolecular Structure and Dynamics, 34(6), 1282–12897. doi: 10.1080/07391102.2015.1077343
   PubMed Web of Science ®Google Scholar
• Awasthi, M., Singh, S., Pandey, V. P., & Dwivedi, U. N. (2018). Modulation in the conformational and stability attributes of the Alzheimer's disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis. Journal of Biomolecular Structure and Dynamics, 36(2), 407–422. doi: 10.1080/07391102.2017.1279078
   PubMed Web of Science ®Google Scholar
• Belluti, S., Orteca, G., Semeghini, V., Rigillo, G., Parenti, F., Ferrari, E., & Imbriano, C. (2018). Potent anti-cancer properties of phthalimide-based curcumin derivatives on prostate tumor cells. International Journal of Molecular Sciences, 20(1), 28. doi: 10.3390/ijms20010028
   Web of Science ®Google Scholar
• Chanphai, P., & Tajmir-Riahi, H. A. (2017). Binding analysis of antioxidant polyphenols with PAMAM nanoparticles. Journal of Biomolecular Structure and Dynamics, 23, 1–9. doi: 10.1080/07391102.2017.1391124
   Google Scholar
• Chaudhary, M., Kumar, N., Baldi, A., Chandra, R., Babu, M. A., & Madan, J. (2019). Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: Design, synthesis, insilico docking and invitro cytotoxicity analysis. Journal of Biomolecular Structure and Dynamics, 27, 1–19. doi: 10.1080/07391102.2019.1578264
   Google Scholar
• Chrysostomou, A. C., Stylianou, D. C., Constantinidou, A., & Kostrikis, L. G. (2018). Cervical Cancer screening programs in Europe: The transition towards HPV vaccination and population-based HPV testing. Viruses, 10(12), 729. doi: 10.3390/v10120729
   PubMed Web of Science ®Google Scholar
• Chu, W., Rothfuss, J., Zhou, D., & Mach, R. H. (2011). Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay. Bioorganic and Medicinal Chemistry Letters, 21 (8), 2192–2197. doi: 10.1016/j.bmcl.2011.03.015
   PubMed Web of Science ®Google Scholar
• Dou, H., Shen, R., Tao, J., Huang, L., Shi, H., Chen, H., … Wang, T. (2017). Curcumin suppresses the colon cancer proliferation by inhibiting Wnt/β-catenin pathways via mir-130a. Frontiers in Pharmacology, 8, 877.
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., … Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. doi: 10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Gamble, C., McIntosh, K., Scott, R., Ho, K. H., Plevin, R., & Paul, A. (2012). Inhibitory kappa B kinases as targets for pharmacological regulation. British Journal of Pharmacology, 165(4), 802–819. doi: 10.1111/j.1476-5381.2011.01608.x
   PubMed Web of Science ®Google Scholar
• Gatumo, M., Gacheri, S., Sayed, A. R., & Scheibe, A. (2018). Women's knowledge and attitudes related to cervical cancer and cervical cancer screening in Isiolo and Tharaka Nithi counties, Kenya: A cross-sectional study. BMC Cancer, 18(1), 745. doi: 10.1186/s12885-018-4642-9
   PubMedGoogle Scholar
• Jyoti, K., Pandey, R. S., Kush, P., Kaushik, D., Jain, U. K., & Madan, J. (2017). Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells. International Journal of Biological Macromolecules, 98, 50–58. doi: 10.1016/j.ijbiomac.2017.01.109
   PubMed Web of Science ®Google Scholar
• Kamshad, M., Jahanshah Talab, M., Beigoli, S., Sharifirad, A., & Chamani, J. (2018). Use of spectroscopic and zeta potential techniques to study the interaction between lysozyme and curcumin in the presence of silver nanoparticles at different sizes. Journal of Biomolecular Structure and Dynamics, 24, 1–11. doi: 10.1080/07391102.2018.1475258
   Google Scholar
• Kamura, T., & Ushijima, K. (2013). Chemotherapy for advanced or recurrent cervical cancer. Taiwanese Journal of Obstetrics and Gynecology, 52(2), 161–164. doi: 10.1016/j.tjog.2013.04.003
   PubMed Web of Science ®Google Scholar
• Li, H., Wu, X., & Cheng, X. (2016). Advances in diagnosis and treatment of metastatic cervical cancer. Journal of Gynecologic Oncology, 27(4), e43. doi: 10.3802/jgo.2016.27.e43
   PubMed Web of Science ®Google Scholar
• Mahajanakatti, A. B., Murthy, G., Sharma, N., & Skariyachan, S. (2014). Exploring inhibitory potential of curcumin against various cancer targets by in silico virtual screening. Interdisciplinary Sciences: Computational Life Sciences, 6(1), 13–24. doi: 10.1007/s12539-014-0170-8
   PubMed Web of Science ®Google Scholar
• Marquardt, J. U., Gomez-Quiroz, L., Arreguin Camacho, L. O., Pinna, F., Lee, Y. H., Kitade, M., … Thorgeirsson, S. S. (2015). Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. Journal of Hepatology, 63(3), 661–669. doi: 10.1016/j.jhep.2015.04.018
   PubMed Web of Science ®Google Scholar
• Martins, P., Jesus, J., Santos, S., Raposo, L. R., Roma-Rodrigues, C., Baptista, P. V., & Fernandes, A. R. (2015). Heterocyclic anticancer compounds: recent advances and the paradigm shift towards the use of nanomedicine's tool box. Molecules, 20(9), 16852–16891. doi: 10.3390/molecules200916852
   PubMed Web of Science ®Google Scholar
• Mohankumar, K., Sridharan, S., Pajaniradje, S., Singh, V. K., Ronsard, L., Banerjea, A. C., … Rajagopalan, R. (2015). BDMC-A, an analog of curcumin, inhibits markers of invasion, angiogenesis, and metastasis in breast cancer cells via NF-κB pathway–A comparative study with curcumin. Biomedicine & Pharmacotherapy, 74, 178–186. doi: 10.1016/j.biopha.2015.07.024
   PubMed Web of Science ®Google Scholar
• Momtazi, A. A., & Sahebkar, A. (2016). Difluorinated curcumin: A promising curcumin analogue with improved anti-tumor activity and pharmacokinetic profile. Current Pharmaceutical Design, 22(28), 4386–4397.
   PubMed Web of Science ®Google Scholar
• Mushtaq, S., Abbasi, B. H., Uzair, B., & Abbasi, R. (2018). Natural products as reservoirs of novel therapeutic agents. EXCLI Journal, 17, 420–451. doi: 10.17179/excli2018-1174
   PubMed Web of Science ®Google Scholar
• Niu, X., Gao, Y., Yu, Y., Yang, Y., Wang, G., Sun, L., & Wang, H. (2019). Molecular modelling reveals the inhibition mechanism and structure-activity relationship of curcumin and its analogues to Staphylococcal aureus Sortase A. Journal of Biomolecular Structure and Dynamics, 37(5), 1220–1230. doi: 10.1080/07391102.2018.1453380
   PubMed Web of Science ®Google Scholar
• Patel, M. M., & Patel, L. J. (2014). Design, synthesis, molecular docking, and antibacterial evaluation of some novel flouroquinolone derivatives as potent antibacterial agent. The Scientific World Journal, 2014, 1. doi: 10.1155/2014/897187
   Google Scholar
• Prescott, J. A., & Cook, S. J. (2018). Targeting IKK-β in cancer: challenges and opportunities for the therapeutic utilisation of IKK-β inhibitors. Cells, 7(9), 115. doi: 10.3390/cells7090115
   Web of Science ®Google Scholar
• Ratnatilaka Na Bhuket, P., El-Magboub, A., Haworth, I. S., & Rojsitthisak, P. (2017). Enhancement of curcumin bioavailability via the prodrug approach: challenges and prospects. European Journal of Drug Metabolism and Pharmacokinetics, 42(3), 341–353. doi: 10.1007/s13318-016-0377-7
   PubMed Web of Science ®Google Scholar
• Sekar, V. K., Rajendran, K., Vallinayagam, S., Deepak, V., & Mahadevan, S. (2018). Synthesis and characterization of chitosan ascorbate nanoparticles for therapeutic inhibition for cervical cancer and their in silico modeling. Journal of Industrial and Engineering Chemistry, 62, 239–249. doi: 10.1016/j.jiec.2018.01.001
   Web of Science ®Google Scholar
• Soni, N., Jyoti, K., Jain, U. K., Katyal, A., Chandra, R., & Madan, J. (2017). Noscapinoids bearing silver nanocrystals augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in B16F1, mouse melanoma skin cancer cells. Biomedicine & Pharmacotherapy, 90, 906–913. doi: 10.1016/j.biopha.2018.05.153
   PubMed Web of Science ®Google Scholar
• Sood, D., Kumar, N., Rathee, G., Singh, A., Tomar, V., & Chandra, R. (2018). Mechanistic interaction study of bromo-noscapine with bovine serum albumin employing spectroscopic and chemoinformatics approaches. Scientific Reports, 8(1), 16964.
   PubMedGoogle Scholar
• Sufi, S. A., Adigopula, L. N., Syed, S. B., Mukherjee, V., Coumar, M. S., Rao, H. S., & Rajagopalan, R. (2017). In silico and in vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione. Biomedicine & Pharmacotherapy, 85, 389–398. doi: 10.1016/j.biopha.2016.11.040
   PubMed Web of Science ®Google Scholar
• Tan, Z. H., Zhang, Y., Tian, Y., Tan, W., & Li, Y. H. (2016). IκB kinase b mediating the downregulation of p53 and p21 by lipopolysaccharide in human papillomavirus 16+ cervical cancer cells. Chinese Medical Journal, 129 (22), 2703–2707. doi: 10.4103/0366-6999.193463
   PubMed Web of Science ®Google Scholar
• Teymouri, M., Pirro, M., Johnston, T. P., & Sahebkar, A. (2017). Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: A review of chemistry, cellular, molecular, and preclinical features. Biofactors, 43(3), 331–346. doi: 10.1002/biof.1344
   PubMed Web of Science ®Google Scholar
• Theppawong, A., Van de Walle, T., Grootaert, C., Van Hecke, K., Catry, N., Desmet, T., … D'hooghe, M. (2019). Synthesis of non-symmetrical nitrogen-containing curcuminoids in the pursuit of new anticancer candidates. ChemistryOpen, 8(2), 236–247. doi: 10.1002/open.201800287
   PubMed Web of Science ®Google Scholar
• Thiyagarajan, V., Lee, K. W., Leong, M. K., & Weng, C. F. (2017). Potential natural mTOR inhibitors screened by in silico approach and suppress hepatic stellate cells activation. Journal of Biomolecular Structure and Dynamics, 12, 1–15. doi: 10.1080/07391102.2017.1411295
   Google Scholar
• Tilborghs, S., Corthouts, J., Verhoeven, Y., Arias, D., Rolfo, C., Trinh, X. B., & van Dam, P. A. (2017). The role of nuclear factor-kappa B signaling in human cervical cancer. Critical Reviews in Oncology/Hematology, 120, 141–150. doi: 10.1016/j.critrevonc.2017.11.001
   PubMed Web of Science ®Google Scholar
• Veerappan, K., Natarajan, S., Ethiraj, P., Vetrivel, U., & Samuel, S. (2017). Inhibition of IKK-β by celastrol and its analogues - An in silico and in vitro approach. Pharmaceutical Biology, 55(1), 368–373. doi: 10.1080/13880209.2016.1241809
   PubMed Web of Science ®Google Scholar
• Vora, J., Patel, S., Sinha, S., Sharma, S., Srivastava, A., Chhabria, M., & Shrivastava, N. (2019). Molecular docking, QSAR and ADMET based mining of natural compounds against prime targets of HIV. Journal of Biomolecular Structure and Dynamics, 37(1), 131–146. doi: 10.1080/07391102.2017.1420489
   PubMed Web of Science ®Google Scholar
• World health Organization. (2019). Human papillomavirus (HPV) and cervical cancer. Retrieved from https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.
   Google Scholar
• Yadav, P., Bandyopadhyay, A., Chakraborty, A., & Sarkar, K. (2018). Enhancement of anticancer activity and drug delivery of chitosan curcumin nanoparticle via molecular docking and simulation analysis. Carbohydrate Polymer, 182, 188–198. doi: 10.1016/j.carbpol.2017.10.102
   PubMed Web of Science ®Google Scholar
• Yu, Z., Guo, W., Ma, X., Zhang, B., Dong, P., Huang, L., … Deng, W. (2014). Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKK-β/NF-κB signaling pathway in lung cancer cells. Molecular Cancer, 13(1), 203. doi: 10.1186/1476-4598-13-203
   PubMedGoogle Scholar